Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00281853 | Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer | completed | — | 15 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00867295 | Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device(TIVAD) | completed | Phase 3 | 150 | Istanbul UniversityOTHER | 1 | Jun 2, 2010 |
| clinicaltrials |
| NCT00572637 | Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas | completed | Phase 1 | 55 | Ethical Oncology ScienceINDUSTRY | 2 | May 20, 2010 | clinicaltrials |
| NCT00027937 | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | May 14, 2010 | clinicaltrials |
| NCT00925275 | Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors | completed | Phase 1 | 9 | Cellectar, IncINDUSTRY | 1 | May 4, 2010 | clinicaltrials |
| NCT00618124 | A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together | completed | Phase 1 | 77 | PfizerINDUSTRY | 1 | May 3, 2010 | clinicaltrials |
| NCT00615446 | A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors | completed | Phase 1 | 44 | PfizerINDUSTRY | 1 | Apr 30, 2010 | clinicaltrials |
| NCT00773929 | Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer | completed | Phase 1 | 60 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 27, 2010 | clinicaltrials |
| NCT00520390 | A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02) | completed | Phase 1 | 34 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00376727 | Cetuximab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00387322 | Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | completed | Phase 1 / Phase 2 | 42 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00278226 | Motivational Program for Smokers Enrolled in a Methadone Maintenance Program | completed | N/A | 398 | Butler HospitalOTHER | 1 | Mar 24, 2010 | clinicaltrials |
| NCT00003082 | Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 27 | University of ArizonaOTHER | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00006456 | Stereotactic Radiosurgery in Treating Patients With Liver Metastases, Lung Metastases, or Other Advanced Solid Tumors | completed | Phase 2 | 26 | Virginia Commonwealth UniversityOTHER | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00084513 | Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer | completed | Phase 1 | 18 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00433524 | Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the Chest | completed | N/A | 30 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00436397 | A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for Cancer | completed | N/A | 60 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00025454 | R115777 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Feb 8, 2010 | clinicaltrials |
| NCT00990912 | A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002) | completed | Phase 1 / Phase 2 | 20 | Bristol-Myers SquibbINDUSTRY | 0 | Feb 5, 2010 | clinicaltrials |
| NCT00091325 | Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants | completed | Phase 1 | — | University of ArizonaOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00006464 | UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00004220 | Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00004243 | Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00006257 | SU5416 and Paclitaxel in Treating Patients With Advanced Cancer | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00249977 | Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan | completed | Phase 1 | 21 | University of New MexicoOTHER | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00005077 | Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00006485 | Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00004877 | BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 3, 2009 | clinicaltrials |
| NCT00487058 | A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | NovartisINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00520637 | A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) | completed | Phase 1 | 34 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 9, 2009 | clinicaltrials |
| NCT00509613 | Phase 1 Study With Sorafenib and Sirolimus | completed | Phase 1 | — | Radboud University Medical CenterOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00004923 | Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 47 | Yale UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00037804 | Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction | completed | Phase 1 | — | PfizerINDUSTRY | 1 | Aug 14, 2009 | clinicaltrials |
| NCT00955786 | Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 48 | Cylene PharmaceuticalsINDUSTRY | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00091806 | Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors | completed | Phase 1 | 86 | AmgenINDUSTRY | 0 | Jul 10, 2009 | clinicaltrials |
| NCT00503477 | A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00096590 | Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery | completed | — | 60 | National Cancer Institute (NCI)NIH | 1 | May 12, 2009 | clinicaltrials |
| NCT00881244 | Study of AS1411 in Advanced Solid Tumours | completed | Phase 1 | 30 | Antisoma ResearchINDUSTRY | 1 | Apr 15, 2009 | clinicaltrials |
| NCT00863733 | Study of DMXAA (Now Known as ASA404) in Solid Tumors(DMXAA) | completed | Phase 1 | 63 | Cancer Research UKOTHER | 0 | Mar 18, 2009 | clinicaltrials |
| NCT00628732 | A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors | completed | Phase 2 | 36 | Children's Medical Center DallasOTHER | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00116896 | Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors | completed | Phase 1 | 25 | OSI PharmaceuticalsINDUSTRY | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00712504 | Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer | completed | Phase 1 | 49 | PfizerINDUSTRY | 1 | Nov 11, 2008 | clinicaltrials |
| NCT00425204 | Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment | completed | Phase 2 | 31 | AmgenINDUSTRY | 0 | Sep 15, 2008 | clinicaltrials |
| NCT00003705 | BMS-184476 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | San Antonio Cancer InstituteOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00043095 | BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00100958 | Indole-3-Carbinol in Preventing Cancer in Healthy Participants | completed | Phase 1 | — | University of KansasOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00478101 | Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain | completed | Phase 2 | 2,006 | Gachon University Gil Medical CenterOTHER | 0 | Mar 13, 2008 | clinicaltrials |
| NCT00394446 | Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors | completed | Phase 1 | 48 | Myrexis Inc.INDUSTRY | 1 | Feb 13, 2008 | clinicaltrials |
| NCT00552825 | Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children | completed | — | 35 | Sheba Medical CenterOTHER_GOV | 1 | Nov 2, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Jun 11, 2010source: clinicaltrials